BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 18978536)

  • 1. Development of protease inhibitors for protozoan infections.
    McKerrow JH; Rosenthal PJ; Swenerton R; Doyle P
    Curr Opin Infect Dis; 2008 Dec; 21(6):668-72. PubMed ID: 18978536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteases of protozoan parasites.
    Rosenthal PJ
    Adv Parasitol; 1999; 43():105-59. PubMed ID: 10214691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of cysteine protease inhibitors as chemotherapy for parasitic diseases: insights on safety, target validation, and mechanism of action.
    McKerrow JH
    Int J Parasitol; 1999 Jun; 29(6):833-7. PubMed ID: 10480720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs targeting parasite lysosomes.
    Doyle PS; Sajid M; O'Brien T; Dubois K; Engel JC; Mackey ZB; Reed S
    Curr Pharm Des; 2008; 14(9):889-900. PubMed ID: 18473838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The proteases and pathogenicity of parasitic protozoa.
    McKerrow JH; Sun E; Rosenthal PJ; Bouvier J
    Annu Rev Microbiol; 1993; 47():821-53. PubMed ID: 8257117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting DHFR in parasitic protozoa.
    Anderson AC
    Drug Discov Today; 2005 Jan; 10(2):121-8. PubMed ID: 15718161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets.
    Coombs GH; Goldberg DE; Klemba M; Berry C; Kay J; Mottram JC
    Trends Parasitol; 2001 Nov; 17(11):532-7. PubMed ID: 11872398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cysteine protease inhibitors as chemotherapy for parasitic infections.
    McKerrow JH; Engel JC; Caffrey CR
    Bioorg Med Chem; 1999 Apr; 7(4):639-44. PubMed ID: 10353643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cell cycle of parasitic protozoa: potential for chemotherapeutic exploitation.
    Hammarton TC; Mottram JC; Doerig C
    Prog Cell Cycle Res; 2003; 5():91-101. PubMed ID: 14593704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the cell cycle in the pursuit of novel chemotherapies against parasitic protozoa.
    Grant KM
    Curr Pharm Des; 2008; 14(9):917-24. PubMed ID: 18473840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrion of protozoan parasite emerges as potent therapeutic target: exciting drugs are on the horizon.
    Sen N; Majumder HK
    Curr Pharm Des; 2008; 14(9):839-46. PubMed ID: 18473833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting polyamines of parasitic protozoa in chemotherapy.
    Müller S; Coombs GH; Walter RD
    Trends Parasitol; 2001 May; 17(5):242-9. PubMed ID: 11323309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease inhibitors in potential drug development for Leishmaniasis.
    Das P; Alam MN; Paik D; Karmakar K; De T; Chakraborti T
    Indian J Biochem Biophys; 2013 Oct; 50(5):363-76. PubMed ID: 24772958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA topoisomerases as targets for antiprotozoal therapy.
    Bakshi RP; Shapiro TA
    Mini Rev Med Chem; 2003 Sep; 3(6):597-608. PubMed ID: 12871162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty acid synthesis in protozoan parasites: unusual pathways and novel drug targets.
    Goodman CD; McFadden GI
    Curr Pharm Des; 2008; 14(9):901-16. PubMed ID: 18473839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic databases and the search of protein targets for protozoan parasites.
    Timmers LF; Pauli I; Barcellos GB; Rocha KB; Caceres RA; de Azevedo WF; Soares MB
    Curr Drug Targets; 2009 Mar; 10(3):240-5. PubMed ID: 19275560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The acidocalcisome as a target for chemotherapeutic agents in protozoan parasites.
    Docampo R; Moreno SN
    Curr Pharm Des; 2008; 14(9):882-8. PubMed ID: 18473837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reporter genes facilitating discovery of drugs targeting protozoan parasites.
    Dube A; Gupta R; Singh N
    Trends Parasitol; 2009 Sep; 25(9):432-9. PubMed ID: 19720564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyamine transport in parasites: a potential target for new antiparasitic drug development.
    Reguera RM; Tekwani BL; Balaña-Fouce R
    Comp Biochem Physiol C Toxicol Pharmacol; 2005 Feb; 140(2):151-64. PubMed ID: 15907761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New mechanisms of drug resistance in parasitic protozoa.
    Borst P; Ouellette M
    Annu Rev Microbiol; 1995; 49():427-60. PubMed ID: 8561467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.